Kirsty M Hooper
Inflammatory Bowel Disease Drugs: A Focus on Autophagy
Hooper, Kirsty M; Barlow, Peter G; Stevens, Craig; Henderson, Paul
Authors
Prof Peter Barlow P.Barlow@napier.ac.uk
Professor
Dr Craig Stevens C.Stevens@napier.ac.uk
Associate Professor
Paul Henderson
Abstract
Inflammatory bowel disease [IBD] is characterized by chronic inflammation of the gastrointestinal tract. Medications such as corticosteroids, thiopurines, immunomodulators and biologic agents are used to induce and maintain remission; however, response to these drugs is variable and can diminish over time. Defective autophagy has been strongly linked to IBD pathogenesis, with evidence showing that enhancing autophagy may be therapeutically beneficial by regulating inflammation and clearing intestinal pathogens. It is plausible that the therapeutic effects of some IBD drugs are mediated in part through modulation of the autophagy pathway, with studies investigating a wide range of diseases and cell types demonstrating autophagy pathway regulation by these agents.
This review will highlight the current evidence, both in vitro and in vivo, for the modulation of autophagy by drugs routinely used in IBD. A clearer understanding of their mechanisms of action will be invaluable to utilize these drugs in a more targeted and personalized manner in this diverse and often complex group of patients.
Citation
Hooper, K. M., Barlow, P. G., Stevens, C., & Henderson, P. (2017). Inflammatory Bowel Disease Drugs: A Focus on Autophagy. Journal of Crohn's and Colitis, 11(1), 118-127. https://doi.org/10.1093/ecco-jcc/jjw127
Journal Article Type | Review |
---|---|
Acceptance Date | Jun 27, 2016 |
Online Publication Date | Jul 5, 2016 |
Publication Date | Jan 1, 2017 |
Deposit Date | Nov 8, 2016 |
Publicly Available Date | Nov 9, 2016 |
Journal | Journal of Crohn's and Colitis |
Print ISSN | 1873-9946 |
Electronic ISSN | 1876-4479 |
Publisher | Oxford University Press |
Peer Reviewed | Peer Reviewed |
Volume | 11 |
Issue | 1 |
Pages | 118-127 |
DOI | https://doi.org/10.1093/ecco-jcc/jjw127 |
Keywords | Autophagy, drugs, IBD, Crohn's disease, |
Public URL | http://researchrepository.napier.ac.uk/Output/413969 |
Related Public URLs | https://www.research.ed.ac.uk/portal/en/publications/inflammatory-bowel-disease-drugs(cc4c3193-5406-4315-9cfd-018308cd8d46).html |
Files
Inflammatory Bowel Disease Drugs: A Focus on Autophagy
(454 Kb)
PDF
Publisher Licence URL
http://creativecommons.org/licenses/by-nc/4.0/
Copyright Statement
© European Crohn’s and Colitis Organistion (ECCO) 2016. 1
Journal of Crohn's and Colitis, 2016, 1–10
doi:10.1093/ecco-jcc/jjw127
Review Article
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License
(http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium,
provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
You might also like
Evolution and immunopathology of chikungunya virus informs therapeutic development
(2023)
Journal Article
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)
(2021)
Journal Article
Regulation of the expression of DAPK1 by SUMO pathway.
(2019)
Journal Article
Antiviral therapeutic approaches for human rhinovirus infections
(2018)
Journal Article
Downloadable Citations
About Edinburgh Napier Research Repository
Administrator e-mail: repository@napier.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2025
Advanced Search